HIV infection:  what should be considered in approaches for a cure?
Jay A
JA
Levy
Yves
Y
Levy
D019380:Anti-HIV Agents / Q000494:pharmacology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects; D004279:DNA, Viral; D055808:Drug Discovery; D005260:Female; D015316:Genetic Therapy / Q000379:methods / Q000639:trends*; D015658:HIV Infections / Q000235:genetics / Q000628:therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D019713:Receptors, CCR5 / Q000187:drug effects* / Q000235:genetics; D017735:Virus Latency / Q000187:drug effects*
D019380:Anti-HIV Agents; D004279:DNA, Viral; D019713:Receptors, CCR5